News Updates
More Articles
- Biostatisticians: Crucial Choreographers Behind Oncology Breakthroughs
- Safety in Clinical Trials: Preparing for the UK Legislative Changes
- Transparency to Ensure Trust in Research: A Key Element of the UK’s New Clinical Trials Regulations
- Commentary: Launching the mindsON RBQM Expert Working Group
- Commentary: DEI in Clinical Research: A Pause, Not a Permanent Stop
Opportunities in 2021 to Fix the Broken Antibiotics Market
The US Centers for Disease Control and Prevention estimates at least 2.8 million antibiotic-resistant infections occur in the US annually, and more than 35,000 people die. At the same time, investments in new antibiotics to meet the threat are faltering, potentially reducing patient access to life-saving treatments.